There is insufficient high-quality evidence to support the long-term benefits of NSAID therapy to prevent vision loss from cystoid macular edema after cataract surgery, according to a report.Cystoid macular edema (CME) is the most common cause of visua…
An artificial iris is available to an increasing number of patients participating in a clinical trial because of a humanitarian use designation granted by the FDA.The CustomFlex artificial iris prosthesis, manufactured by HumanOptics, is designed for patients with iris defects, iris damage and aniridia. The clinical trial’s sponsor, Clinical Research Consultants, plans to submit a premarket approval (PMA) application to the FDA when the trial is completed.
Corneal cross-linking may provide more benefits than just stopping the progression of keratoconus, according to a speaker at OSN New York 2015.While the technique prevents keratoconus progression, it also can improve uncorrected visual acuity and best …
World-renowned cardiologist Valentin Fuster, MD, PhD, Director of Mount Sinai Heart and Physician-in-Chief of The Mount Sinai Hospital, is undertaking a three-year study, known as the TANSNIP-PESA study, to determine whether a workplace-based lifestyle…
WAIKOLOA, Hawaii — At Hawaiian Eye, John P. Berdahl, MD, encourages his fellow cornea surgeons to convert from DSEK to DMEK due to better patient outcomes and despite a relatively steep learning curve.
WAIKOLOA, Hawaii — At Hawaiian Eye, Richard L. Lindstrom, MD, discusses the implementation of the “less drops” approach to cataract and refractive corneal procedures at Minnesota Eye Consultants.